PDS Biotechnology Employee Directory
Biotechnology ResearchNew Jersey, United States11-50 Employees
PDS Biotech is a clinical-stage biotechnology company focused on developing and commercializing T-cell Stimulating Immunotherapies (TSI) based on the Versamune platform to harness the body's immune response against cancer. The company operates in the biotechnology research industry and is based in Princeton, New Jersey, at 303a College Road East, 08540. It has between 11 and 50 employees. In 2025, PDS Biotech announced the launch of VERSATILE-003, a Phase 3 trial for Versamune HPV, and a Phase 3 trial of Versamune in HPV16+ head and neck cancer, with related preclinical data presented and conference activity noted. The company maintains a website at https://pdsbiotech.com.